| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. (RARE) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. RARE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.7K | $3.51M | - | |
| CFO | 88.9K | $2.35M | - | |
| Other | 79.9K | $2.12M | - | |
| Other | 79.9K | $2.12M | - | |
| VP | 50.5K | $1.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Parschauer Karah Herdman77 | EVP And Chief Legal Officer | Sell | 3,161 | $45.25 | $143,035.25 | -5.3% | +6.0% | +13.3% | |
| Mar 1, 2023 | Bedrosian Camille L64 | EVP And Chief Medical Officer | Sell | 3,881 | $45.25 | $175,615.25 | -7.7% | +6.0% | +13.3% | |
| Mar 1, 2023 | Kassberg Thomas Richard68 | Cbo &EVP | Sell | 1,968 | $45.27 | $89,091.36 | -0.8% | +6.0% | +13.3% | |
| Mar 1, 2023 | Huizenga Theodore Alan65 | SVP, Chief Accounting Officer | Sell | 100 | $45.65 | $4,565.00 | -0.4% | +6.0% | +13.3% | |
| Mar 1, 2023 | Huang Dennis Karl63 | See Remarks | Sell | 389 | $45.65 | $17,757.85 | -0.5% | +6.0% | +13.3% | |
| Mar 1, 2023 | Pinion John Richard73 | See Remarks | Sell | 3,755 | $45.26 | $169,951.30 | -4.5% | +6.0% | +13.3% | |
| Mar 1, 2023 | Harris Erik75 | EVP &Chief Commercial Officer | Sell | 3,664 | $45.25 | $165,796.00 | -6.0% | +6.0% | +13.3% | |
| Feb 28, 2023 | Huizenga Theodore Alan65 | SVP, Chief Accounting Officer | Sell | 639 | $43.40 | $27,732.60 | -3.9% | +8.8% | +18.6% | |
| Dec 30, 2022 | Kakkis Emil D72 | President &CEO | Sell | 19,582 | $45.57 | $892,351.74 | -3.5% | -16.6% | +3.2% | |
| Dec 21, 2022 | Huizenga Theodore Alan65 | SVP, Chief Accounting Officer | Sell | 2,031 | $43.96 | $89,282.76 | -11.1% | -13.1% | +3.2% |